Reata Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Reata Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Reata Pharmaceuticals Inc
Access all reports
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes innovative medicines in the areas of inflammation and immunology. The company is focused on discovering, developing, and commercializing novel therapeutics for patients with immune-mediated inflammatory diseases. The company has different phase II and phase III product candidates.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
RETA
Country
đșđž United States